Company Listing
Chiasma

Chiasma is a biopharmaceutical company developing oral drugs that were previously only available by injection, providing patients with pain-free medications that are self-administered. In June 2015, the company submitted a New Drug Application to the US FDA seeking approval of its lead product, oral octreotide capsules, for the maintenance treatment of adults with acromegaly. Chiasma went public in July 2015.

 

BACK
Location
New York and Jerusalem, Israel
CEO
Mark Fitzpatrick
Abingworth Partner
Vincent Miles
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Chiasma is a biopharmaceutical company developing oral drugs that were previously only available by injection, providing patients with pain-free medications that are self-administered. In June 2015, the company submitted a New Drug Application to the US FDA seeking approval of its lead product, oral octreotide capsules, for the maintenance treatment of adults with acromegaly. Chiasma went public in July 2015.

 

Location
New York and Jerusalem, Israel
CEO
Mark Fitzpatrick
Abingworth Partner
Vincent Miles
Website Address
BACK
 
Copyright Abingworth 2017